突变的亨廷丁在亨廷顿病中赋予了细胞自主表型 - - 来自iPSC的微质细胞
Nina Stöberl1, Jasmine Donaldson2, Caroline S Binda2
1School of Biosciences, Cardiff University, Cardiff, UK. stoberln@cardiff.ac.uk.
Scientific reports
|November 22, 2023
概括
突变的亨廷丁基因表达直接损害了亨廷顿病 (HD) 中的微质功能. 这种细胞自主功能障碍会导致炎症和减少细胞化,甚至在症状出现之前.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 亨廷顿病 (HD) 是一种神经退行性疾病,与亨廷丁基因 (HTT) 中的CAG重复扩张有关.
- 大脑的免疫细胞微质细胞与HD病理有关,但它们的确切作用以及突变HTT (mHTT) 是否直接影响它们仍然不清楚.
- 目前有争议的是,HD中的微质功能障碍是mHTT的细胞自主作用,还是对更广泛的神经退行性环境的反应.
研究的目的:
- 研究突变型亨廷丁 (mHTT) 对亨廷顿病 (HD) 中人类微质功能细胞自主作用.
- 使用诱导多能干细胞 (iPSC) 建立人类细胞模型,研究HD微质细胞.
- 为了确定mHTT表达是否直接损害微质功能,如炎症,细胞和内细胞.
主要方法:
- 来自各种CAG重复长度 (Q109,Q60,Q33) 和对照组 (Q22) 的高发病患者的同源诱导多能干细胞 (iPSC).
- 差异化的iPSC线路变成iPSC衍生的微质细胞 (iPSC-微质细胞).
- 在没有外部免疫刺激的情况下,评估基底微质功能,包括促炎性细胞因子的产生,细胞和内细胞因子.
主要成果:
- 患HD患者衍生的iPSC-微细胞表现出基底功能障碍,包括增加的促炎性细胞因子产生.
- 在携带扩展CAG重复的iPSC-微细胞中,细胞和内细胞能力受损.
- 这些功能缺陷发生的独立于免疫刺激,表明mHTT的细胞自主作用.
结论:
- 突变的亨廷丁 (mHTT) 表达直接损害人类微质功能以细胞自主的方式.
- 这种内在的微质功能障碍导致神经炎症,并在亨廷顿病中减少细胞清除机制.
- 这些发现支持一种模型,即早期的细胞自主微质功能障碍在疾病发病前出现明显的神经退行,与预先表现的患者的观察结果一致.
更多相关视频
05:35Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route
Published on: May 31, 2022
3.0K
08:27Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
6.2K
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
